Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 
Ukraine, US and Europe Seek Unified Peace Framework With Security Guarantees for Kyiv 
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Supreme Court to Weigh Trump’s Power to Remove FTC Commissioner 
Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Trump Signals Two Final Candidates for Fed Chair, Calls for Presidential Input on Interest Rates 
SpaceX CEO Elon Musk Denies Reports of $800 Billion Valuation Fundraise 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Trump Criticizes Insurers as Debate Over Extending Obamacare Subsidies Intensifies 
U.S. Greenlights Nvidia H200 Chip Exports to China With 25% Fee 
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies 
U.S. State Department Reverts to Times New Roman in Push for “Professionalism” 
Bolivia Orders Pre-Trial Detention of Former President Luis Arce Over Embezzlement Probe 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
